Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635
| ACET Stock | USD 0.72 0.02 2.86% |
Slightly above 55% of Adicet Bio's private investors are presently thinking to get in. The analysis of overall sentiment of trading Adicet Bio stock suggests that some investors are interested at this time. Adicet Bio's investing sentiment can be driven by a variety of factors including economic data, Adicet Bio's earnings reports, geopolitical events, and overall market trends.
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimm
Read at businesswire.com
 |
Adicet Bio Fundamental Analysis
We analyze Adicet Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adicet Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adicet Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Adicet Bio is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Adicet Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adicet Bio stock to make a market-neutral strategy. Peer analysis of Adicet Bio could also be used in its relative valuation, which is a method of valuing Adicet Bio by comparing valuation metrics with similar companies.
Peers
Adicet Bio Related Equities
| VOR | Vor Biopharma | 5.56 | ||||
| ALEC | Alector | 4.80 | ||||
| NKTX | Nkarta | 4.12 | ||||
| IGMS | IGM Biosciences | 1.69 | ||||
| GLUE | Monte Rosa | 1.00 | ||||
| KROS | Keros Therapeutics | 0.85 | ||||
| CGEM | Cullinan Oncology | 0.25 | ||||
| STOK | Stoke Therapeutics | 0.21 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.89 | ||||
| AGIO | Agios Pharm | 1.73 | ||||
| TNYA | Tenaya Therapeutics | 2.27 | ||||
| PLRX | Pliant Therapeutics | 2.92 | ||||
| EWTX | Edgewise Therapeutics | 3.91 | ||||
| BCYC | Bicycle Therapeutics | 5.41 | ||||
| ACRV | Acrivon Therapeutics, | 8.00 |
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.